HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick J Bednarski Selected Research

Antineoplastic Agents (Antineoplastics)

12/2021Correlation Analysis of Protein Expression of 10 HDAC/Sirtuin Isoenzymes with Sensitivities of 23 Anticancer Drugs in 17 Cancer Cell Lines and Potentiation of Drug Activity by Co-Treatment with HDAC Inhibitors.
2/2020Pharmacological Evaluation of the Anticancer Activity of Extracts and Fractions of Lannea barteri Oliv. (Anacardiaceae) on Adherent Human Cancer Cell Lines.
8/2009Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
12/2007Characterization of three B-cell lymphoma cell lines from chemotherapy resistant patients with respect to in vitro sensitivity to 21 antitumor agents, ABC-transporter expression and cellular redox status.
12/2004No correlation between GSH levels in human cancer cell lines and the cell growth inhibitory activities of platinum diamine complexes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick J Bednarski Research Topics

Disease

40Neoplasms (Cancer)
12/2021 - 05/2003
7Pain (Aches)
03/2022 - 02/2015
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2011 - 11/2007
4Epilepsy (Aura)
03/2022 - 02/2015
4Chemical and Drug Induced Liver Injury
03/2022 - 11/2018
4Carcinoma (Carcinomatosis)
12/2021 - 01/2017
4Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 05/2003
3Phototoxic Dermatitis (Phototoxicity)
12/2021 - 05/2011
3Urinary Bladder Neoplasms (Bladder Cancer)
12/2020 - 01/2006
3Breast Neoplasms (Breast Cancer)
06/2008 - 12/2007
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020 - 01/2018
2Lung Neoplasms (Lung Cancer)
10/2014 - 05/2003
2B-Cell Lymphoma (Lymphoma, B Cell)
11/2012 - 12/2007
1Ovarian Neoplasms (Ovarian Cancer)
06/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021
1Seizures (Absence Seizure)
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2018
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2018
1Myalgia
03/2015
1Multiple Myeloma
01/2014
1Decompression Sickness (Bends)
08/2012

Drug/Important Bio-Agent (IBA)

14Cisplatin (Platino)FDA LinkGeneric
10/2018 - 09/2003
7flupirtineIBA
03/2022 - 02/2015
7PlatinumIBA
01/2018 - 12/2004
7LigandsIBA
10/2014 - 04/2009
6Glutathione (Reduced Glutathione)IBA
12/2020 - 09/2003
5EnzymesIBA
12/2021 - 05/2003
5Antineoplastic Agents (Antineoplastics)IBA
12/2021 - 12/2004
4Pharmaceutical PreparationsIBA
03/2022 - 02/2008
4ezogabine (retigabine)IBA
03/2022 - 02/2015
41-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2021 - 01/2016
4Gentian Violet (Violet, Crystal)FDA Link
06/2021 - 03/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2018 - 09/2003
41,2-cyclohexanediamine (dach)IBA
08/2009 - 12/2004
3Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2007
3temoporfinIBA
12/2021 - 10/2018
3Glutathione Peroxidase GPX1IBA
12/2021 - 01/2020
3Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2019 - 02/2015
3Carboplatin (JM8)FDA LinkGeneric
10/2018 - 12/2004
3Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2018 - 12/2004
3Cytostatic AgentsIBA
01/2018 - 10/2014
2Potassium Channels (Potassium Channel)IBA
03/2022 - 01/2022
2Methanol (Carbinol)IBA
06/2021 - 03/2009
2PeroxidasesIBA
12/2020 - 03/2014
2Opioid Analgesics (Opioids)IBA
01/2019 - 11/2018
2Analgesics (Analgesic Drugs)IBA
01/2019 - 03/2015
2Glutathione PeroxidaseIBA
11/2012 - 04/2007
2Etoposide (VP 16)FDA LinkGeneric
11/2012 - 01/2006
2Methotrexate (Mexate)FDA LinkGeneric
11/2012 - 01/2006
2Methyl EthersIBA
01/2009 - 11/2007
22-phenylindoleIBA
06/2008 - 12/2007
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2007 - 04/2007
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
12/2007 - 04/2007
2Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
04/2007 - 09/2003
1Histone Deacetylases (Histone Deacetylase)IBA
12/2021
1IsoenzymesIBA
12/2021
1Messenger RNA (mRNA)IBA
12/2021
1SirtuinsIBA
12/2021
1Sirtuin 1IBA
12/2021
1Histone Deacetylase InhibitorsIBA
12/2021
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021
1Biological ProductsIBA
07/2021
1BromidesIBA
06/2021
1benzamideIBA
12/2020
1SulfonamidesIBA
12/2020
1diphenyl (biphenyl)IBA
12/2020
1Therapeutic UsesIBA
01/2019
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2018
1quinolineIBA
01/2018
1naphthaleneIBA
01/2018
11,2,4-triazoleIBA
01/2018
1QuinolinesIBA
01/2018
1benzotriazoleIBA
01/2018
1Urea (Carbamide)FDA LinkGeneric
01/2017
1Phenylthiourea (Phenylthiocarbamide)IBA
01/2017
1ThioureaIBA
01/2017
1Photosensitizing Agents (Photosensitizers)IBA
01/2016
1Oleic Acid (Oleate)IBA
01/2016
1AmidesIBA
01/2016
1CopperIBA
10/2014
1MisonidazoleIBA
03/2014
1sigma Receptors (sigma Receptor)IBA
01/2014
1ProdrugsIBA
07/2013
13-hydroxyflavoneIBA
12/2012
1Bortezomib (Velcade)FDA Link
11/2012
1hydroxide ionIBA
09/2012
1Cytotoxins (Cytolysins)IBA
09/2012
1MetalsIBA
08/2012
1NitrogenIBA
05/2011
1CarbonIBA
12/2010
1HexanesIBA
08/2009
1diamminedichlorodihydroxyplatinum IVIBA
08/2009
1EthersIBA
04/2009

Therapy/Procedure

4Therapeutics
01/2022 - 12/2007
3Photochemotherapy (Photodynamic Therapy)
12/2021 - 10/2018
3Drug Therapy (Chemotherapy)
03/2014 - 12/2007
1Radiotherapy
03/2014